Mubasher TV
Contact Us Advertising   العربية

Jamjoom Pharmaceuticals Factory Co. is pleased to announce the release of its inaugural ESG & Sustainability Report for the fiscal year ended 31 December 2024

JAMJOOM PHARMA 4015 -7.41% 156.10 -12.50
Element List Explanation
Announcement Detail The report outlines the Company’s overarching framework for integrating environmental, social, and governance (ESG) priorities into its corporate strategy and day-to-day operations. It reflects Jamjoom Pharma’s ongoing commitment to sustainability and responsible business practices, while aligning with the Global Reporting Initiative (GRI) standards.

Jamjoom Pharma’s sustainability vision complements the Kingdom of Saudi Arabia’s broader economic diversification goals and Vision 2030 objectives, particularly in advancing access to quality medicines, supporting national talent development, and fostering environmentally responsible growth.

The report highlights the Company’s progress across four strategic ESG pillars. These include initiatives to improve affordable access to healthcare across regional markets; investments in employee well-being and training, and efforts to minimize the environmental impact of operations by enhancing resource efficiency. Governance enhancements were also prioritized, to support long-term accountability and transparency.

Please refer to the attached document to view the full ESG report.

Attached Documents   
JP Sustainability Report 2024

Comments